Effect of human milk oligosaccharides on the fecal microbiome and metabolism in infants with congenital heart disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400086091

Enrollment

Unknown

Registered

2024-06-25

Start date

2024-08-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

A:feed with HMO whole protein formula

B:feed with HMO amino acid formula

C:feed with Common formula milk

Eligibility

Sex/Gender

All

Age

No minimum to 0.1 Years

Inclusion criteria

Inclusion criteria: Day 0 – 28 of term non-breastfed newborns diagnosed with CHD.

Exclusion criteria

Exclusion criteria: Combined with severe digestive tract malformation, dysplasia, tumor and other diseases

Design outcomes

Primary

Measure	Time frame
Fecal Micro biome;	—

Secondary

Measure	Time frame
Perioperative gastrointestinal tolerance;Physical growth indicators;	—

Countries

China

Contacts

Public ContactGui Juan

Guangdong Provincial People's Hospital

guijuan224@126.com+86 135 8055 4106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026